Figures & data
Table 1 Baseline characteristics by groupTable Footnotea
Table 2 Blood glucose, lipid, adipokine, and Hs-CRP profilesTable Footnotea
Figure 1 Proportion of subjects in each group with a diagnosis of hypertension (A), diabetes, (B), coronary artery disease (C), and peripheral artery disease (D).
![Figure 1 Proportion of subjects in each group with a diagnosis of hypertension (A), diabetes, (B), coronary artery disease (C), and peripheral artery disease (D).](/cms/asset/935b9e42-7da0-4faf-a347-31900494ab27/dcop_a_168963_f0001_b.jpg)
Table 3 Coronary artery calcification and liver densityTable Footnotea
Figure 2 Group mean values±SD for body mass index (A), waist-to-hip ratio (B), muscle tissue cross-sectional area (muscle tissue CSA; C), muscle tissue attenuation (D), visceral adipose tissue CSA (E), visceral adipose tissue attenuation (F), subcutaneous adipose tissue CSA (G), and total adipose tissue CSA (H), in control subjects (open bars) and subjects with Global initiative for chronic Obstructive Lung Disease (GOLD) 1 (gray bars) and 2+ (black bars) COPD.
![Figure 2 Group mean values±SD for body mass index (A), waist-to-hip ratio (B), muscle tissue cross-sectional area (muscle tissue CSA; C), muscle tissue attenuation (D), visceral adipose tissue CSA (E), visceral adipose tissue attenuation (F), subcutaneous adipose tissue CSA (G), and total adipose tissue CSA (H), in control subjects (open bars) and subjects with Global initiative for chronic Obstructive Lung Disease (GOLD) 1 (gray bars) and 2+ (black bars) COPD.](/cms/asset/c1754798-e4f2-447f-8cdc-5810fb198f6b/dcop_a_168963_f0002_b.jpg)
Table 4 Predictors of cardiovascular comorbidities in multiple regression analyses